Dispute Resolution Hotline: India-Bombay High Court refuses to grant anti-arbitration injunction (Ravi Arya v Palmview Overseas)
Posted by By nishithadmin at 25 February, at 11 : 13 AM Print
Warning: count(): Parameter must be an array or an object that implements Countable in /web/qlc/nishith.tv/htdocs/wp-content/themes/Video/single_blog.php on line 46
Warning: count(): Parameter must be an array or an object that implements Countable in /web/qlc/nishith.tv/htdocs/wp-content/themes/Video/single_blog.php on line 52
INDIA—BOMBAY HIGH COURT REFUSES TO GRANT ANTI-ARBITRATION INJUNCTION (RAVI ARYA V PALMVIEW OVERSEAS)
This article was originally published in the 23rd January 2019 edition of
SUMMARY:
In Ravi Arya v Palmview Overseas, the Bombay High Court ruled that when remedies are available to the party seeking an injunction under the Arbitration and Conciliation Act, 1996, an anti-arbitration injunction cannot be obtained to circumvent provisions of the Act. The present case raises a critical issue of appointment of a single arbitrator by multiple parties having a conflict of interest inter se.
For complete article, please click here.
Legal500 Asia-Pacific 2019: Tier 1 for Dispute Resolution, International Tax, Investment Funds, Labour & Employment, TMT and Corporate M&A
Chambers and Partners Asia Pacific 2019: Band 1 for Labour & Employment, Lifesciences, Tax and TMT
AsiaLaw 2019: Ranked ‘Outstanding’ for Technology, Labour & Employment, Private Equity, Regulatory and Tax
IFLR 1000 Asia Pacific 2019: Tier 1 for TMT and Private Equity
RSG-Financial Times: India’s Most Innovative Law Firm (2014, 2015 & 2017)
RSG-FT Awards (London) 2016: Asia Pacific’s Most Innovative Law Firm
Merger Market 2018: Fastest growing M&A practice
Benchmark Litigation Asia Pacific 2018: Tier 1 for Tax
IDEX: Tier 1 for Dispute Resolution
Asian Mena Counsel’s In-House Community Firms survey 2018- NDA voted as the only firm from India to excel in the Life Sciences sector
The Most Innovative Law Firm in Asia-Pacific
DISCLAIMER
The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.